Expectant parents who have herpes often face a wave of questions and concerns as they prepare for delivery. One of the biggest fears is whether they might pass the virus to their baby during childbirth. This concern is understandable—most cases of neonatal herpes stem from exposure to the herpes simplex virus (HSV) in the birth canal during labor. For anyone living with HSV, particularly those newly diagnosed or unsure of their status, this can create a sense of uncertainty during an already vulnerable time.
What adds to the anxiety is that many people whose babies develop neonatal herpes don’t realize they were carrying the virus. According to national surveillance data, a large proportion of mothers of affected infants had no known history of genital herpes. This lack of symptoms or prior diagnosis can make it feel as though the risk comes out of nowhere. And for those who acquire HSV during pregnancy, especially in the final weeks, the risk of transmission is higher, further intensifying concern.
The good news is that neonatal herpes is rare. In high-income countries, it affects somewhere between 1 in 3,000 to 1 in 20,000 live births. Still, its potential consequences are serious. Without prompt treatment, it can lead to brain inflammation, widespread infection, or even death. Early diagnosis and medical care are critical, but so is being informed before delivery.
This post will walk you through what herpes transmission during childbirth actually looks like, how the risk is managed, and the steps your care team can take to keep your baby safe.
Understanding Neonatal Herpes
Neonatal herpes is a rare but serious infection that can occur when a newborn is exposed to the herpes simplex virus (HSV) during delivery. This usually happens through contact with the virus in the birth canal. Although the condition is uncommon, it requires urgent medical attention because of the potential for life-threatening complications.
The majority of neonatal herpes cases are caused by HSV-2, though HSV-1 has become more common due to shifting sexual behavior patterns. What makes neonatal herpes particularly concerning is that symptoms are not always visible at birth. Without treatment, the virus can spread quickly and lead to long-term neurological damage or, in severe cases, death.
The timing of a parent’s infection plays a major role in transmission risk. The danger is highest when someone contracts HSV for the first time late in pregnancy. In these cases, the body hasn’t had time to produce protective antibodies, which normally help shield the baby during delivery. If genital lesions or viral shedding are present during labor, especially in a first-time infection, the chances of transmission can rise significantly.
Complicating things further, HSV can be passed on even without visible sores. Many people shed the virus asymptomatically, meaning they don’t realize they’re contagious. This is why some cases of neonatal herpes happen even when no one suspected any risk.
The outcomes for an infected newborn can vary. Some babies develop skin or eye lesions. Others may experience encephalitis, a type of brain inflammation that can cause seizures and developmental delays. In more severe cases, the virus spreads throughout the body and affects multiple organs, which increases the risk of death.
Prompt recognition and treatment, usually with intravenous antiviral medication, are crucial. The earlier care begins, the better the chances for a healthy recovery.
Primary vs. Recurrent Infection: Why Timing Matters
When it comes to herpes transmission during childbirth, timing can make a significant difference. The body’s immune response, shaped by whether a person is experiencing a first infection or a recurrence, plays a key role in how much risk is passed on to the baby.
Primary Infection in Late Pregnancy
If someone contracts herpes for the first time during the last weeks of pregnancy, the risk of passing it to the newborn is much higher. Without prior exposure, the body hasn’t developed antibodies to fight off the virus or protect the baby through the placenta. In these situations, transmission rates can range from 30 to 50 percent.
Babies born under these circumstances are more likely to develop widespread or central nervous system disease. This is partly because the mother’s immune system hasn’t had a chance to produce protective antibodies and also because primary infections tend to involve a higher viral load. Both factors make it easier for the virus to reach and affect the baby during delivery.
Recurrent Outbreaks
In contrast, when someone has a known history of HSV and experiences a recurrence near delivery, the outlook is much more reassuring. Even if viral shedding occurs at the time of birth, the risk of transmission is typically less than 1 percent, especially if the birthing parent is on antiviral medication.
This is thanks to the body’s existing antibodies, which are passed to the baby during pregnancy. These antibodies act like a protective buffer, reducing both the likelihood of the virus being passed on and the severity of illness if it is.
The difference between a new infection and a recurrence shows just how powerful maternal immunity can be. It also underscores the importance of knowing one’s HSV status and working closely with healthcare providers throughout pregnancy.
How to Reduce Transmission Risk Before Labor
Proactive planning before delivery is one of the most effective ways to protect a newborn from herpes transmission during childbirth. With the right steps in place, the risk of passing the virus to a baby can be greatly minimized.
Start Suppressive Therapy Around Week 36
Beginning daily antiviral medication, such as valacyclovir or acyclovir, at 36 weeks gestation is a widely recommended step for those with a known history of genital herpes. This treatment reduces the chance of viral shedding during labor and lowers the risk of outbreaks at delivery. As a result, fewer people need a cesarean section based solely on herpes symptoms.
Valacyclovir in particular is well tolerated in late pregnancy and offers higher drug levels in the body than acyclovir, which may enhance its effectiveness. Suppressive therapy helps ensure the genital tract remains free of active lesions at delivery, which is key to reducing neonatal risk.
Monitor for Symptoms in the Final Weeks
Even if no sores are visible, it’s important to watch for subtle warning signs. Tingling, itching, or burning sensations—known as prodromal symptoms—can indicate that the virus is active. These symptoms should be shared with your doctor right away, as they may influence delivery planning.
Visual exams alone cannot always detect when someone is shedding the virus. By staying alert to how your body feels in the final weeks and reporting any concerns, you give your care team the information they need to act early and lower potential risks.
Avoid Sexual Contact with New Partners Late in Pregnancy
A new HSV infection acquired late in pregnancy carries a much higher risk of transmission to the baby because there has not been enough time for the immune system to develop protective antibodies. For this reason, health authorities strongly advise against sexual contact with new or HSV-positive partners during the third trimester unless both partners are fully informed of their HSV status.
Even without symptoms, a partner can still transmit HSV. Most new infections come from people who do not know they are contagious, which is why limiting new exposures in late pregnancy is especially important.
Have a Birth Plan That Includes HSV Management
Discussing your HSV status with your OB/GYN or midwife early on allows you to build a birth plan that accounts for your needs. If you are using suppressive therapy, anticipating potential symptoms, or considering cesarean delivery as a precaution, these details should be documented and revisited in the final weeks of pregnancy.
When needed, your provider may also coordinate with pediatricians or infectious disease specialists to prepare for postnatal care. Educating yourself and communicating openly with your care team can create a safer, more confident birth experience.
Delivery Options and Precautions
When preparing for childbirth with a history of HSV, understanding your delivery options is an important part of protecting your baby. The method of delivery—vaginal or cesarean—is typically based on your symptoms and HSV history in the final weeks of pregnancy.
When Vaginal Delivery Is Safe
For people with recurrent herpes who are on suppressive therapy and have no symptoms at the time of labor, vaginal delivery is generally considered safe. The absence of visible sores or prodromal signs like tingling or burning means the risk of transmitting HSV to the baby is very low. Weekly swabs beginning around 36 weeks may be used to check for viral shedding, though this approach is not universally practiced.
Suppressive therapy not only reduces the chance of an outbreak but also lowers the likelihood of needing a cesarean delivery. This makes vaginal birth a viable and safe option for many who are managing HSV under medical guidance.
When Cesarean Section Is Recommended
A cesarean section is advised when there are active genital lesions or symptoms suggesting an outbreak—such as pain, itching, or unusual sensations—at the time of labor. This precaution helps prevent the baby from coming into contact with the virus during birth.
The recommendation becomes even more urgent if the HSV infection is newly acquired in the third trimester, when the body has not yet built antibodies to pass along to the baby. A cesarean may also be critical if the water breaks and delivery does not occur within a few hours, especially in someone with recent symptoms.
The Importance of a Flexible Birth Plan
It’s essential to discuss your HSV history and management strategy with your care team early in your pregnancy. A well-prepared birth plan should include details about antiviral treatment, symptom monitoring, and delivery preferences. Input from specialists, including pediatricians and infectious disease experts, can also help ensure your plan is thorough and personalized.
As your due date approaches, revisit this plan regularly. New symptoms or changes in health may prompt adjustments, and staying flexible will help your providers make decisions that prioritize both your health and your baby’s safety.
What Happens After Birth? Newborn Protection Measures
After delivery, if there was any concern about herpes exposure during labor, your baby’s care team will take immediate steps to ensure their safety. Even if your baby appears healthy, monitoring begins right away to catch any early signs of infection.
Careful Observation and Testing
Newborns whose parents had active genital herpes at the time of delivery are monitored closely. This includes watching for symptoms like fever, unusual tiredness, or skin changes. In some cases, doctors may run tests such as surface swabs or bloodwork to detect the virus early, especially if the maternal infection was newly acquired or symptomatic during labor.
Close observation makes a critical difference. Early diagnosis allows for prompt treatment, which is essential in preventing more serious complications from neonatal HSV. This cautious approach helps healthcare providers respond quickly if needed, even before symptoms are fully visible.
Antiviral Therapy When Needed
If there is a high risk of exposure—such as a primary infection late in pregnancy or active lesions during birth—your baby may be tested and started on antiviral medication as a precaution. This treatment typically involves intravenous acyclovir, which may continue for 14 to 21 days depending on the situation. In some cases, oral suppressive therapy may follow to further protect the infant.
Starting treatment early not only improves survival rates but also reduces the chance of long-term effects like neurological problems. Decisions around testing and medication are based on maternal history, the baby’s exam findings, and clinical judgment.
Breastfeeding Considerations
Breastfeeding is safe for people with HSV as long as there are no sores on the nipple or surrounding breast skin. The virus is not passed through breast milk, so the risk to the baby is minimal when lesions are absent.
If a sore does appear on the breast, it’s important to avoid feeding from that side until it fully heals. Milk can still be expressed from the unaffected breast and offered to the baby, and maintaining milk supply during treatment helps support a smooth return to breastfeeding once healing is complete.
With prompt care, clear communication, and a thoughtful plan, most babies born to HSV-positive parents remain healthy and thrive.
How to Protect Your Baby from HSV After Birth
Even after a safe delivery, protecting your baby from herpes simplex virus (HSV) continues to matter. Most postnatal HSV cases are caused by exposure to HSV-1, often through contact with a caregiver who has an active cold sore. The good news is that with a few simple precautions, you can help prevent this type of transmission.
Avoid Contact from People with Cold Sores
If someone has a visible cold sore, they should not kiss or have close facial contact with your baby. HSV-1 can be passed through a kiss or even a quick snuggle if the virus is active, and newborns are especially vulnerable. It’s a good idea to kindly ask family and friends to wait until any cold sores have completely healed before visiting or holding your infant.
Even well-meaning relatives may not realize that a seemingly harmless cold sore poses a risk, so gentle reminders can go a long way in keeping your baby safe.
Don’t Share Utensils, Bottles, or Pacifiers
Sharing saliva through items like spoons, cups, or pacifiers can also transmit HSV-1. This is true even when someone doesn’t appear to have symptoms, since the virus can be present in saliva without obvious signs. To reduce this risk, keep your baby’s items separate and make sure anyone caring for your baby understands not to share their own food or drinks.
Wash Hands Before Handling the Baby
Handwashing remains one of the simplest and most powerful ways to protect your newborn. If you or someone else has HSV, even without visible lesions, it’s important to wash hands thoroughly before touching the baby, especially after using the bathroom, changing a dressing, or touching the face.
HSV can be shed from areas without obvious sores, so hand hygiene is essential, particularly in the early weeks of your baby’s life.
Know the Signs That Need Medical Attention
Neonatal HSV can sometimes develop even with precautions, and the symptoms can be subtle. Watch for signs such as a fever, low energy, difficulty feeding, or unusual rashes or blisters. These may resemble other infections, so it’s best to seek medical attention quickly if something feels off.
Early evaluation and treatment make a significant difference. If HSV is caught and treated early, the chance of a good outcome increases dramatically.
By staying informed and cautious, you can help ensure that your baby continues to be protected after birth.
Emotional Reassurance: You’re Doing Everything Right
Worry is natural when you’re navigating pregnancy with a herpes diagnosis, especially when it comes to your baby’s safety. But it’s important to know that your concern, and the actions you’re taking, are part of what makes you an attentive and protective parent. With thoughtful planning and medical guidance, the risk of passing herpes to your newborn can be reduced to a very low level.
Starting antiviral treatment at 36 weeks and making informed choices about delivery, such as considering a cesarean section if symptoms are present, are both effective strategies for keeping your baby safe. In most cases involving recurrent herpes, these steps bring the chance of neonatal transmission to below one percent. That is a reassuring figure, supported by both research and clinical experience.
Healthcare providers today are also better equipped to support you. Improvements in education and awareness among both patients and professionals have led to more compassionate care and more effective prevention strategies throughout pregnancy and birth.
It is also essential to understand that having herpes does not make you a danger to your child. The majority of babies born to people with herpes are completely healthy, especially when the parent has a recurrent infection. In these situations, the body has already produced protective antibodies that help safeguard the baby during delivery. With open communication and careful planning, the likelihood of complications remains low.
You are not alone in this, and the steps you are already taking—educating yourself, preparing with your provider, and staying alert to changes—demonstrate your commitment and care. Your baby is in good hands.
Moving Forward with Confidence and Care
Becoming a parent already comes with so many unknowns, and adding herpes into the mix can make things feel even more uncertain. But here’s the truth: with knowledge, preparation, and the right support, you can absolutely protect your baby and have a healthy, positive birth experience.
Understanding how herpes transmission works, taking steps like antiviral therapy and delivery planning, and knowing what to expect after birth are all part of a proactive approach that puts your baby’s well-being first. The risk of neonatal herpes is low—especially when you’re informed and involved in your care. You are doing what matters most by showing up, asking questions, and staying engaged.
If you’ve found this article helpful, consider joining our mailing list. You’ll receive updates, new articles, and practical resources to support you every step of the way.
References
Alberto, D. M. D. C., & Indira, I. E. (2018). Herpes genitalis disertai lesi ekstragenital primer pada gravida trimester III dengan HIV stadium I. Medicina-Buenos Aires, 49.
American Academy of Pediatrics. (2015). Herpes Simplex. In Red Book: 2015 Report of the Committee on Infectious Diseases (30th ed.).
Andrews, W. W., Kimberlin, D. F., Whitley, R., Cliver, S. P., Ramsey, P. S., & Deeter, R. (2006). Valacyclovir therapy to reduce recurrent genital herpes in pregnant women. American Journal of Obstetrics and Gynecology, 194(3), 774–781.
Arvin, A. (1991). Relationships between maternal immunity to herpes simplex virus and the risk of neonatal herpesvirus infection. Reviews of Infectious Diseases, 13(Suppl 11), S953–S956.
Baker, D. (2007). Consequences of herpes simplex virus in pregnancy and their prevention. Current Opinion in Infectious Diseases, 20, 73–76.
Barrett, M. E., Heller, M., Stone, H. F., & Murase, J. (2016). Primary herpes simplex virus infection of the nipple in a breastfeeding woman. Cutis, 97(6), E10–E11.
Brown, Z., Wald, A., Morrow, R., Selke, S., Zeh, J., & Corey, L. (2003). Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA, 289(2), 203-209.
Brown, Z., Gardella, C., Wald, A., Morrow, R., & Corey, L. (1998). Genital herpes complicating pregnancy. Obstetrics and Gynecology Clinics of North America, 25(3), 845–856.
Centers for Disease Control and Prevention. (2023). Genital Herpes – CDC Fact Sheet.
Cherpes, T. L., Matthews, D. B., & Maryak, S. A. (2012). Neonatal herpes simplex virus infection. Clinical Obstetrics and Gynecology, 55(4), 938-944.
Clarke, E., Patel, R., Dickins, D., Fidler, K., Jackson, A., Kingston, M., Jones, C., Lyall, H., Nicholson, M., Pelosi, E., Porter, D., Powell, G., & Foley, E. (2024). Joint British Association for Sexual Health and HIV and Royal College of Obstetricians and Gynaecologists national UK guideline for the management of herpes simplex virus (HSV) in pregnancy and the neonate (2024 update). International Journal of STD & AIDS.
Dunphy, L., Ulaganathan, P., & Furara, S. (2025). Herpes simplex-2 meningitis presenting with headache in pregnancy. BMJ Case Reports, 18(2).
Forsgren, M., & Malm, G. (1996). Herpes simplex virus and pregnancy. Scandinavian Journal of Infectious Diseases. Supplementum, 100, 14–19.
Gardella, C., Handsfield, H. H., & Whitley, R. (2008). Neonatal herpes – the forgotten perinatal infection. Sexually transmitted diseases, 35(1), 22–24.
Grossman, J. H., Wallen, W., & Sever, J. (1981). Management of Genital Herpes Simplex Virus Infection During Pregnancy. Obstetrics & Gynecology, 58, 1–4.
Guerra, B., Puccetti, C., & Cervi, F. (2012). The genital herpes problem in pregnancy. Giornale Italiano di Dermatologia e Venereologia, 147(5), 455-466.
Guleria, K., & Sethi, N. (2020). Herpes in Pregnancy. Journal of Fetal Medicine, 7, 49–55.
Hayderi, L. E., Caucanas, M., & Nikkels, A. (2012). Herpes simplex virus infections of the nipple. The Open Dermatology Journal, 6, 29–32.
Henrot, A. (2002). Mother-infant and indirect transmission of HSV infection: treatment and prevention. Annales de dermatologie et de venereologie, 129(4 Pt 2), 533–549.
Hollier, L., & Wendel, G. (2008). Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection. Cochrane Database of Systematic Reviews, 1, CD004946.
Ivanova, R., Vasilyev, V. V., Rogozina, N., Grineva, A., & Ushakova, G. M. (2021). Congenital herpes simpleх: modern approach to prevention, diagnosis, and treatment. CHILDREN INFECTIONS.
Jacobs, R. (1998). Neonatal herpes simplex virus infections. Seminars in Perinatology, 22(1), 64–71.
Jaiyeoba, O., Amaya, M., Soper, D. E., & Kilby, J. M. (2012). Preventing neonatal transmission of herpes simplex virus. Clinical Obstetrics and Gynecology, 55(2), 510–520.
Kimberlin, D. W., & Whitley, R. J. (2007). Herpes simplex: children and adolescents. Seminars in Pediatric Infectious Diseases, 18(4), 214–219.
Kimberlin, D., & Baley, J. (2013). Guidance on management of asymptomatic neonates born to women with active genital herpes lesions. Pediatrics, 131, e635–e646.
Kimberlin, D., Weller, S., Whitley, R., Andrews, W., Hauth, J., Lakeman, F., & Miller, G. (1998). Pharmacokinetics of oral valacyclovir and acyclovir in late pregnancy. American Journal of Obstetrics and Gynecology, 179(4), 846–851.
Lindsay, M. (2006). HSV neutralizing antibodies: Further refinement in preventing neonatal Herpes infection. American Journal of Obstetrics and Gynecology, 195(1), 4–6.
Looker, K. J., Magaret, A. S., May, M. T., Turner, K. M. E., Vickerman, P., Newman, L. M., & Gottlieb, S. L. (2017). First estimates of the global and regional incidence of neonatal herpes infection. The Lancet Global Health, 5(3), e300–e309.
Mahant, A., Trejo, F.E., Aguilan, J., Sidoli, S., & Herold, B. (2022). P31: Antigenic target, antibody subclass, function and glycans and SARS-CoV-2 coinfection impact the placental transfer of herpes simplex virus antibodies. American Journal of Reproductive Immunology, 87, 91.
Nimmagadda, S., & Spahn, J. (1994). Herpes simplex virus-2 (HSV-2) type-specific antibody correlates of protection in infants exposed to HSV-2 at birth. Pediatrics.
Perozzi, K. J., Zalice, K. K., Howard, V., & Skariot, L. (2007). HSV: What you need to know to care for your pregnant patient. MCN, The American Journal of Maternal/Child Nursing, 32(6), 345–350.
Picone, O. (2017). Genital herpes and pregnancy: Epidemiology, clinical manifestations, prevention and screening. Gynecologie Obstetrique Fertilite & Senologie, 45(12), 642–654.
Pittet, L., & Curtis, N. (2020). Postnatal Exposure to Herpes Simplex Virus: To Treat or Not to Treat? Pediatric Infectious Disease Journal.
Riley, G., Cloete, E., & Walls, T. (2022). Challenges of timely investigation and treatment of neonatal herpes simplex virus infection. Journal of Paediatrics and Child Health, 59.
Safer, D. A. (2012). Reducing Your Risk of Genital Herpes.
Saini, A., Patodia, J., & Mittal, J. (2021). A Preterm With Disseminated Neonatal Herpes Simplex Virus (HSV) After Kangaroo Mother Care. Journal of Neonatology, 35, 242–245.
Schiffer, J. T., & Corey, L. (2013). Rapid host immune response and viral dynamics in herpes simplex virus-2 infection. Nature medicine, 19(3), 280–290.
Sharma, D., Murki, S., & Pratap, O. T. (2015). Neonatal Herpes Encephalitis: A Rare Cause of Neonatal Refractory Seizures. Journal of Pediatrics & Neonatal Care, 2(3).
Stanberry, L. R. (2006). Neonatal Herpes in Premature Infants: A Special Problem. Pediatrics, 118(6), 2543–2544.
Stanton, J. (2014). Management Strategies During Pregnancy to Prevent Neonatal Herpes.
Stephenson-Famy, A., & Gardella, C. (2014). Herpes simplex virus infection during pregnancy. Obstetrics and gynecology clinics of North America, 41(4), 601–614.
Stokes, S., Zahler-Miller, C., & Dunn, K. (2024). Diagnosis and management of a herpes nipple infection that resulted in neonatal HSV encephalitis. BMJ Case Reports, 17.
Stone, K. M., Brooks, C. A., Guinan, M., & Alexander, E. R. (1989). National surveillance for neonatal herpes simplex virus infections. Sexually Transmitted Diseases, 16(3), 152–156.
Westhoff, G., Little, S., & Caughey, A. (2011). Herpes Simplex Virus and Pregnancy: A Review of the Management of Antenatal and Peripartum Herpes Infections. Obstetrical & Gynecological Survey, 66, 629–638.
